Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | HCID 68505870 | HCID 68505870 | — |
| Product | HCID 46938212 | HCID 46938212 | 33% |
Reaction Steps
(2R,4S)-Methyl 4-(3-oxo-2,3-dihydroisoxazol-5-yl)-2-(3-(trifluoromethyl)phenyl)piperidine-1-carboxylate (0.155 g, 0.42 mmol) was dissolved in hydrogen bromide (33% in acetic acid, 3.30 mL, 18.83 mmol) and the mixture was stirred at room temperature overnight. The solvent was evaporated and the residue purified by preparative HPLC (Instrument: FractionLynx II, Mobilphase: gradient 5-95% MeCN in 0.2% NH3, pH 10, Column: Xbridge Prep C18 5 μm OBD 19*150 mm) to yield 5-((2R,4S)-2-(3-(trifluoromethyl)phenyl)piperidin-4-yl)isoxazol-3(2H)-one (43 mg, 33%). 1H NMR (600 MHz, dmso) δ 1.35 (q, 1H), 1.47 (dq, 1H), 1.87 (d, 1H), 2.00 (d, 1H), 2.69-2.77 (m, 1H), 2.83-2.91 (m, 1H), 3.08-3.14 (m, 1H), 3.75 (d, 1H), 5.74 (s, 1H), 7.50-7.55 (m, 1H), 7.55-7.59 (m, 1H), 7.64-7.68 (m, 1H), 7.71 (s, 1H). HRMS Calculated for [C15H15F3N2O2+H]+: 313.1164. Found: 313.1144
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08415378B2 |
|---|
| Source dataset | uspto-grants-2013_04 |
|---|
| ORD ID | ord-5e2b0d39fb4946c4bad8673191e982ca |
|---|
| Source note | uspto-grants-2013_04 |
|---|